Interleukin-7 Is Associated with Clinical and Pathological Activities in Immunoglobulin A Nephropathy and Protects the Renal Proximal Tubule Epithelium from Cellular Fibrosis

Abstract

Objective

Diagnosis of immunoglobulin A nephropathy (IgAN) requires the evaluation of renal biopsy specimens. However, renal biopsy is an invasive procedure and is not frequently performed for various reasons. Thus, recognized noninvasive biomarkers for predicting IgAN progression are urgently needed.

Methods

In the present study, we included 86 IgAN patients with renal biopsy from June 2015 to May 2016 and had their plasma interleukin-7 (IL-7) level measured with ELISA. The association between the plasma IL-7 level and clinico-pathological characteristics was analyzed. Immunohistochemical staining was used to assay the in situ expression of IL-7 in vivo. Western blotting was performed to examine the production of extracellular matrix, p-mTOR and the markers of autophagy under the treatment of IL-7 after TGF-β1 stimulation in renal tubular epithelial cells.

Results

IL-7 was significantly decreased in patients with IgAN compared to healthy subjects (2.3077 vs. 8.6294 pg/mL, P<0.0001). There was a significant difference in the plasma IL-7 level between tubular atrophy/interstitial fibrosis T0 and T2 classes (P=0.0064). A lower plasma IL-7 value in patients at the time of biopsy indicated a poor renal outcome. In addition, IL-7 was over-expressed in renal tubular epithelial cells and significantly attenuated transforming growth factor βl-induced extracellular matrix production by suppression of cellular autophagy via activation of mTOR1 signaling.

Conclusion

These results suggested that IL-7 might be a noninvasive biomarker for predicating IgAN. It protected renal proximal tubular epithelial cells from cellular fibrosis by inhibiting autophagy via mTORl signaling.

Keywords

IgA nephropathy / biomarker / IL-7 / cellular fibrosis

References

[1] WyattRJ, JulianBA. IgA nephropathy. N Engl J Med, 2013, 368(25): 2402-2414

[2] Working Group of the International IgA Nephropathy Networkthe Renal Pathology SocietyCattranDC, CoppoR, et al.. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int, 2009, 76(5): 534-545

[3] van RoonJA, VerweijMC, WijkMW, et al.. Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages. Arthritis Rheum, 2005, 52(6): 1700-1710

[4] HarrisonC. Autoimmune disease: Targeting IL-7 reverses type 1 diabetes. Nat Rev Drug Discov, 2012, 11(8): 599

[5] Ben-DavidH, SharabiA, ParameswaranR, et al.. A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis. Immunology, 2009, 128(2): 245-252

[6] LundströmW, FewkesNM, MackallCL. IL-7 in human health and disease. Semin Immunol, 2012, 24(3): 218-224

[7] ZhaiSB, ZhaoLY, ZhangY, et al.. Interleukin-7 stimulation inhibits nephrin activation and induces podocyte injury. Biochem Biophys Res Commun, 2018, 507(1–4): 100-105

[8] PenarandaC, KuswantoW, HofmannJ, et al.. IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proc Natl Acad Sci USA, 2012, 109(31): 12 668-12 673

[9] VenetF, DemaretJ, BlaiseBJ, et al.. IL-7 Restores T lymphocyte immunometabolic failure in septic shock patients through mTOR activation. J Immunol, 2017, 199(5): 1606-1615

[10] AllgäuerA, SchreinerE, FerrazziF, et al.. IL-7 Abrogates the immunosuppressive function of human double-negative T cells by activating Akt/mTOR signaling. J Immunol, 2015, 195(7): 3139-3148

[11] AylettCH, SauerE, ImsengS, et al.. Architecture of human mTOR complex 1. Science, 2016, 351(6268): 48-52

[12] DunlopEA, TeeAR. mTOR and autophagy: a dynamic relationship governed by nutrients and energy. Semin Cell Dev Biol, 2014, 36: 121-129

[13] GermainN, ViltartO, LoyensA, et al.. Interleukin-7 plasma levels in human differentiate anorexia nervosa, constitutional thinness and healthy obesity. PloS One, 2016, 11(9): e0161890

[14] De BenedettiF, MassaM, PignattiP, et al.. Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. J Rheumatol, 1995, 22(8): 1581-1585

[15] NeuhausTJ, ShahV, CallardRE, et al.. T-lymphocyte activation insteroid-sensitive nephrotic syndrome in childhood. Nephrol Dial Transplant, 1995, 10(8): 1348-1352

[16] PellegriniM, CalzasciaT, ElfordAR, et al.. Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. Nat Med, 2009, 15(5): 528-536

[17] ZhangW, DuJY, YuQ, et al.. Interleukin-7 produced by intestinal epithelial cells in response to Citrobacter rodentium infection plays a major role in innate immunity against this pathogen. Infect Immun, 2015, 83(8): 3213-3223

[18] HigginsDF, KimuraK, BernhardtWM, et al.. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest, 2007, 117(12): 3810-3820

[19] KawaiT, MasakiT, DoiS, et al.. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab Invest, 2009, 89(1): 47-58

[20] HsiehPF, LiuSF, LeeTC, et al.. The role of IL-7 in renal proximal tubule epithelial cells fibrosis. Mol Immunol, 2012, 50(1–2): 74-82

[21] HuangM, SharmaS, ZhuL, et al.. IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis. J Clin Invest, 2002, 109(7): 931-937

[22] JiangL, XuL, MaoJ, et al.. Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis. J Am Soc Nephrol, 2013, 24(7): 1114-1126

[23] LieberthalW, LevineJS. The role of the mammalian target of rapamycin (mTOR) in renal disease. J Am Soc Nephrol, 2009, 20(12): 2493-2502

[24] NovalicZ, van der WalAM, LeonhardWN, et al.. Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease. J Am Soc Nephrol, 2012, 23(5): 842-853

[25] WangS, WilkesMC, LeofEB, et al.. Noncanonical TGF-beta pathways, mTORC1 and Abl, in renal interstitial fibrogenesis. Am J Physiol Renal Physiol, 2010, 298(1): F142-149

[26] BaisantryA, BhayanaS, RongS, et al.. Autophagy induces prosenescent changes in proximal tubular S3 segments. J Am Soc Nephrol, 2016, 27(6): 1609-1616

[27] DingY, KimS, LeeSY, et al.. Autophagy regulates TGF-beta expression and suppresses kidney fibrosis induced by unilateral ureteral obstruction. J Am Soc Nephrol, 2014, 25(12): 2835-2846

[28] ZhuJ, ZhangW, ZhangL, et al.. IL-7 suppresses macrophage autophagy and promotes liver pathology in Schistosoma japonicum-infected mice. J Cell Mol, 2018, 22(7): 3353-3363